RemeGen Co Ltd banner

Intrinsic Value

Is RemeGen Co Ltd undervalued or overvalued?

See the intrinsic value estimate for RemeGen Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RemeGen Co Ltd Intrinsic Value
LOCKED
Unlock
Today vs. history

RemeGen Co Ltd looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with RemeGen Co Ltd’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RemeGen Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price ¥93.62
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RemeGen Co Ltd

Fundamental Analysis

What RemeGen Does

Biotechnology Health Care

RemeGen Co Ltd is a Chinese biopharmaceutical company that discovers and develops antibody-based medicines. Its main products target autoimmune diseases and cancer, so the company works in two areas where doctors need treatments that can control the immune system or attack tumor cells more precisely than older drugs.

Headquarters
China CN
Employees
3 048
IPO date
Nov 9, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
RemeGen Co Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one RemeGen Co Ltd stock?

The intrinsic value for RemeGen Co Ltd (688331) under the Base Case is hidden CNY.

Is RemeGen Co Ltd stock undervalued or overvalued?

Compared with the current market price of 93.62 CNY, the stock appears hidden.

Back to Top